Related Experiment Video
Updated: Sep 28, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Effectiveness of Urate-Lowering Therapy for Renal Function in Patients With Chronic Kidney Disease: A Meta-Analysis
Xiuping Liang1,2, Xiang Liu3,2, Duohui Li2
1Department of Rheumatology and Immunology, Department of Medicine, West China Hospital, Sichuan University, Chengdu, China.
Insights
Urate-lowering therapy (ULT) effectively reduces serum uric acid in chronic kidney disease (CKD) patients. However, current evidence does not demonstrate significant renoprotective benefits of ULT in CKD, though it appears safe.
Area of Science:
- Nephrology
- Pharmacology
- Clinical Trials
Background:
- Hyperuricemia is a known comorbidity of chronic kidney disease (CKD).
- The efficacy and safety of urate-lowering therapy (ULT) for renal outcomes in CKD patients remain uncertain.
- This meta-analysis evaluates the effectiveness of ULT in improving kidney function in CKD.
Approach:
- A systematic meta-analysis of randomized clinical trials (RCTs) was conducted.
- Data were sourced from PubMed, Embase, MEDLINE, and Cochrane Central Register of Controlled Trials.
- Outcomes included changes in renal function, serum uric acid (SUA), serum creatinine, and adverse events.
Key Points:
- ULT significantly lowered SUA levels (SMD: -2.70; 95% CI: -3.71, -1.69).
- No significant renoprotective effects of ULT were observed compared to control therapies.
- Subgroup and sensitivity analyses confirmed the stability of these findings.
- Adverse event risks were not elevated in the ULT group.
Conclusions:
- ULT effectively reduces SUA in CKD patients.
- Insufficient evidence currently supports the renoprotective role of ULT in CKD.
- ULT is considered safe for use in CKD patients.
Abstract:
Background and Objective: Hyperuricemia is closely related to chronic kidney disease (CKD). The effects of urate-lowering therapy (ULT) on renal outcomes are uncertain, and whether it is warranted in CKD patients is currently unclear. The aim of our meta-analysis of randomized clinical trials (RCTs) was to assess the effectiveness and safety of ULT for improving kidney function in patients with CKD. Methods: RCTs were retrieved from the PubMed, Embase, MEDLINE and Cochrane Central Register of Controlled Trials databases. The meta-analysis was performed using Review Manager and Stata/SE software. The outcomes were changes in renal function and serum uric acid (SUA), serum creatinine, and adverse events. Results: Twelve RCTs with 1,469 participants were included in the meta-analysis. ULT was found to effectively lower SUA (standard mean difference (SMD): -2.70; 95% confidence interval (CI): -3.71, -1.69) but the renoprotective effects were not superior to those of control therapy (placebo or usual therapy), which were stable in the subgroup analyses and sensitivity analyses. Regarding adverse events, their risks did not increase in the ULT group compared with the control group and were stable in the sensitivity analyses. Conclusion: The findings of our meta-analysis suggested that ULT can effectively lower SUA, but there is insufficient evidence to support the renoprotective effects of ULT in CKD patients. In addition, ULT is safe for patients with CKD. Systematic Review Registration: https://clinicaltrials.gov/, identifier PROSPERO (CRD42020200550).
More Related Videos
04:37Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
05:34A Mouse Model to Evaluate the Long-Term Structural and Functional Outcomes after the Reversal of Prolonged Unilateral Ureteric Obstruction
Published on: July 18, 2025
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Chronic Kidney Disease III: Interprofessional Care
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acute Kidney Injury IV: Diagnostic Studies and Prevention